Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Clinical effects of tipifarnib in hematological malignancies

Dec. 29, 2003

New Zealand approves Thalidomide for multiple myeloma

Dec. 29, 2003

Target enrollment reached in ASCENT trial of DN-101

Dec. 29, 2003

Exelixis files IND for phase III trial of XL-119

Dec. 29, 2003

Esters of camptothecins with enhanced anticancer activity described in recent patent

Dec. 29, 2003

COX17 as a novel target for NSCLC

Dec. 23, 2003

Mitotic kinesin KSP inhibitors reported by Cytokinetics and GlaxoSmithKline

Dec. 23, 2003

Photobarr PDT recommended for approval in E.U.

Dec. 23, 2003

Array BioPharma and AstraZeneca to develop MEK program for oncology

Dec. 23, 2003

Alexion and XOMA collaborate on c-MPL agonist antibody development

Dec. 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...